Advertisement

Journal of Tongji Medical University

, Volume 13, Issue 4, pp 252–256 | Cite as

Correlative factors of left ventricular hypertrophy in end-stage renal disease

  • Dai Yong
  • He Shi-jiao
  • Yu Ying
  • Zhu Lan-ying
  • Peng Bao
  • Liu Jian-bo
  • Tang Shi-cong
Article

Summary

The correlative factors of left ventricular hypertrophy (LVH) in 287 endstage renal disease (ESRD), admitted from 1983 to 1992, were analyzed. 52% of patients had LVH including 54 % of patients on hemodialysis, 75 % of patients with peritoneal dialysis and 38 % of transplanted patients. Single factor analysis indicated that age, blood pressure, serum creatinine and BUN, hemoglobin, serum alkaline phosphatase, aortic valve disease and present DSRD therapy were related to LVH. Multiple logistic regression analysis indicated that the most important factors which independently related to LVH in all patients studied, were management of present ESRD treatment, age, hypertension and high serum alkaline phosphatase. In a subset of patients with severe LVH, high serum alkaline phosphatase level, high systolic blood pressure and age were the predictive factors. In patients on dialysis, the most important variable were age and high serum alkaline phosphatase. Hypertension was the sole predictor of LVH in the transplant group.

Key words

end-stage renal disease left ventricular hypertrophy dialysis transplantation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ma K W, Greene E L, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis, 1992;19(6):505PubMedGoogle Scholar
  2. 2.
    Rostand S G, Brunzel J D, Cannon R Oet al. Cardiovascular complications in renal failure. J Am Soc Nephrol, 1991;2(6):1053PubMedGoogle Scholar
  3. 3.
    Deligiannis A, Paschalidou E, Sakellariou Get al. Changes in left ventricular anatomy during hemodialysis, continuous ambulatory peritoneal dialysis and after renal transplantation. Proc Eur Dial Transplant Ass, 1985;21:185Google Scholar
  4. 4.
    Salinas C A, Ulloa F, Hermosillo J Aet al. Change in the mass and function of the left ventricle after renal transplantation. Arch Inst Cardiol Mex, 1991;61:527Google Scholar
  5. 5.
    Nail R B, Gosling P, Price Cet al. Comparative study of alkaline phosphatase isoenzymes, bone histology, and skeletal radiography in dialysis bone disease. Br Med J, 1977;I: 1307Google Scholar
  6. 6.
    McGoingle R J, Fowler M B, Timmis A Bet al. Uremic cardiomyopathy: potential role of vitamine D and parathyroid hormone. Nephron, 1984;36:94CrossRefGoogle Scholar
  7. 7.
    de Wardener H E, MacGregor G A. The relation of a circulating sodium transport inhibitor to hypertension. Medicine, 1983;62:310PubMedCrossRefGoogle Scholar
  8. 8.
    Fraser C L, Sarnachi P, Atieff A Iet al. Effects of parathyroid hormone in uremia on calcium transport in rat brain synaptosmoes. Kidney Int, 1986;29:159Google Scholar
  9. 9.
    Iseki K, Massry S G, Campese WM. Hypercalcemia and hypertension: role of parathyroid hormone. Kidney Int, 1986;29:248Google Scholar
  10. 10.
    Rambausck M, Ritz E, Mahis Oet al. Myocardial hypertrophy in rats with renal insufficiency. Kidney Int, 1985, 28:775CrossRefGoogle Scholar
  11. 11.
    Ren J F, Hakki A H, Kotler M Net al. Exercise systolic blood pressure: a powerful determinant of increased left ventricular mass in patients with hypertension. J Am Coll Cardiiol, 1985;5:1224CrossRefGoogle Scholar
  12. 12.
    Gardin J M, Matin K, White Det al. Effect of aging on peak systolic well stress in normal subjects. Clin Res, 1985;33:7Google Scholar

Copyright information

© Springer 1993

Authors and Affiliations

  • Dai Yong
    • 1
  • He Shi-jiao
    • 1
    • 3
  • Yu Ying
    • 1
    • 2
  • Zhu Lan-ying
    • 1
    • 2
  • Peng Bao
    • 1
    • 2
  • Liu Jian-bo
    • 1
  • Tang Shi-cong
    • 1
    • 2
  1. 1.Department of NephrologyShenzhen People’s HospitalShenzhen
  2. 2.Kidney Research InstituteSun Yatsen University of Medical SciencesChina
  3. 3.Now Heshan County HospitalGaungdong Province

Personalised recommendations